G

Genedrive PLC
LSE:GDR

Watchlist Manager
Genedrive PLC
LSE:GDR
Watchlist
Price: 2.4 GBX -2.04% Market Closed
Market Cap: 13m GBX
Have any thoughts about
Genedrive PLC?
Write Note

Genedrive PLC
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Genedrive PLC
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
G
Genedrive PLC
LSE:GDR
Common Stock
ÂŁ1.8m
CAGR 3-Years
25%
CAGR 5-Years
29%
CAGR 10-Years
28%
Oxford Nanopore Technologies PLC
LSE:ONT
Common Stock
ÂŁ86k
CAGR 3-Years
34%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Diaceutics PLC
LSE:DXRX
Common Stock
ÂŁ169k
CAGR 3-Years
0%
CAGR 5-Years
281%
CAGR 10-Years
N/A
Ergomed PLC
LSE:ERGO
Common Stock
ÂŁ508k
CAGR 3-Years
2%
CAGR 5-Years
2%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Common Stock
ÂŁ4.5m
CAGR 3-Years
2%
CAGR 5-Years
12%
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Common Stock
ÂŁ680k
CAGR 3-Years
0%
CAGR 5-Years
16%
CAGR 10-Years
22%
No Stocks Found

Genedrive PLC
Glance View

Market Cap
13m GBX
Industry
Life Sciences Tools & Services

Genedrive Plc is a holding company, which engages in the development of drugs and disease diagnostics. The Company’s Genedrive device is a molecular diagnostics platform for the diagnosis of infectious diseases and for use in patient stratification (genotyping), pathogen detection and other indications. The Company’s commercial products include Genedrive MT-RNR1, Genedrive BioPlex, Genedrive HCV ID Kit and Genedrive 96 SARS-CoV-2 Ki. Genedrive MT-RNR1 is a commercial test for antibiotic induced hearing loss. Genedrive BioPlex is developed for the determination of military biothreats from pathogens. Genedrive HCV ID Kit is effective in the diagnosis of Hepatitis C Virus (HCV) infection in resource limited settings. Genedrive 96 SARS-CoV-2 Ki is a plate format of a COVID-19 molecular test for high throughput use, which detects all known variants of COVID-19.

GDR Intrinsic Value
0.41 GBX
Overvaluation 83%
Intrinsic Value
Price
G

See Also

What is Genedrive PLC's Common Stock?
Common Stock
1.8m GBP

Based on the financial report for Dec 31, 2023, Genedrive PLC's Common Stock amounts to 1.8m GBP.

What is Genedrive PLC's Common Stock growth rate?
Common Stock CAGR 10Y
28%

Over the last year, the Common Stock growth was 32%. The average annual Common Stock growth rates for Genedrive PLC have been 25% over the past three years , 29% over the past five years , and 28% over the past ten years .

Back to Top